| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HUMANIGEN, INC | COO and CFO | Stock Option (Right to Buy) | 600K | $2.72M | $4.53 | 27 Jul 2022 | Direct |
| Aquestive Therapeutics, Inc. | Director | Stock Option (right to purchase) | 42K | $143K | $3.41 | 11 Jun 2025 | Direct |
| DBV Technologies S.A. | Director | Ordinary Shares | 12K | $20.9K | $1.74 | 25 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | 11 Jun 2025 | 1 | $143K | 4 | Director | 12 Jun 2025, 13:59 |
| AQST | Aquestive Therapeutics, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 13:51 |
| DBVT | DBV Technologies S.A. | 25 Aug 2023 | 1 | $18.2K | 4 | Director | 28 Aug 2023, 16:35 |
| AQST | Aquestive Therapeutics, Inc. | 21 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 12:27 |
| AQST | Aquestive Therapeutics, Inc. | 16 Aug 2022 | 1 | $0 | 4 | Director | 17 Aug 2022, 15:35 |
| HGEN | HUMANIGEN, INC | 27 Jul 2022 | 1 | $0 | 4 | COO and CFO | 29 Jul 2022, 18:30 |
| HGEN | HUMANIGEN, INC | 12 Jan 2022 | 1 | $0 | 4 | COO and CFO | 14 Jan 2022, 16:06 |
| HGEN | HUMANIGEN, INC | 31 Dec 2021 | 1 | $0 | 4 | COO and CFO | 04 Jan 2022, 17:20 |
| DBVT | DBV Technologies S.A. | 10 Jun 2021 | 1 | $48.7K | 4 | Director | 11 Jun 2021, 16:54 |